---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-004614"
form_type: "8-K"
ticker: "WINT"
cik: "0000946486"
company_name: "WINDTREE THERAPEUTICS INC /DE/"
filed_at: "2024-02-16T23:59:59+00:00"
generated_at: "2026-06-06T00:37:13.301108+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Windtree Therapeutics interim CFO John Tattory resigns; CEO takes over CFO role

## Summary
- John A. Tattory resigned as Interim CFO effective Feb 15, 2024, by mutual agreement as part of cost-cutting measures, with no dispute.
- CEO Craig E. Fraser will serve as principal financial officer on an interim basis while retaining President and CEO roles.
- Tattory will continue consulting via LifeSci Associates at an agreed hourly rate.

## SEC filing metadata
- accession: 0001437749-24-004614
- form_type: 8-K
- ticker: WINT
- cik: 0000946486
- company_name: WINDTREE THERAPEUTICS INC /DE/
- filed_at: 2024-02-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/946486/000143774924004614/0001437749-24-004614-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/946486/000143774924004614/wint20240215_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-004614
- JSON: https://secwatch.observer/filing/0001437749-24-004614.json
- Plain text: https://secwatch.observer/filing/0001437749-24-004614.txt

## Key facts
- Executive change
  Craig E. Fraser was appointed as Principal Financial Officer at WINDTREE THERAPEUTICS INC /DE/.
  - Action: assumed
  - Role: Principal Financial Officer
  source text: Craig E. Fraser, who currently serves as the Company’s President, Chief Executive Officer and Chairman of the Board of Directors, will assume the responsibilities of principal financial officer for purposes of the Securities Exchange Act of 1934, as amended, on an interim basis.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924004614/0001437749-24-004614-index.htm
- Executive change
  John A. Tattory resigned as Interim Chief Financial Officer at WINDTREE THERAPEUTICS INC /DE/.
  - Action: resigned
  - Role: Interim Chief Financial Officer
  source text: On February 15, 2024, Windtree Therapeutics, Inc. (the “Company”) and John A. Tattory mutually agreed to Mr. Tattory’s resignation from his positions as the Interim Chief Financial Officer and principal financial officer of the Company, effective February 15, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/946486/000143774924004614/0001437749-24-004614-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.